MYNRIAH Trademark

Trademark Overview


On Wednesday, June 2, 2021, a trademark application was filed for MYNRIAH with the United States Patent and Trademark Office. The USPTO has given the MYNRIAH trademark a serial number of 79314858. The federal status of this trademark filing is REGISTERED as of Tuesday, January 11, 2022. This trademark is owned by NOVARTIS AG. The MYNRIAH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations
mynriah

General Information


Serial Number79314858
Word MarkMYNRIAH
Filing DateWednesday, June 2, 2021
Status700 - REGISTERED
Status DateTuesday, January 11, 2022
Registration Number6610399
Registration DateTuesday, January 11, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Sunday, May 29, 2022NOTIFICATION PROCESSED BY IB
Tuesday, May 3, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 2, 2022FINAL DISPOSITION PROCESSED
Thursday, February 10, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, January 11, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 6, 2021NOTICE OF PUBLICATION
Monday, September 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 20, 2021ASSIGNED TO EXAMINER
Tuesday, July 20, 2021APPLICATION FILING RECEIPT MAILED
Thursday, July 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 12, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 1, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB